Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. (SHSE:600535) from Yan Xijun and Wu Nai Feng for CNY 4 million on March 27, 2016. Under the terms of the deal, Yan Xijun plans to transfer 5% stake to Yan Kaijing for CNY 1.8 million and Wu Nai Feng plans to transfer 6% stake to Li Yunhui for CNY 2.16 million. Yan Kaijing and Li Yunhu cancelled the acquisition of 11% stake in Tasly Pharmaceutical Group Co., Ltd. (SHSE:600535) from Yan Xijun and Wu Nai Feng on March 27, 2017.